货号:A147258
同义名:
AGN 192024; 17-phenyl trinor Prostaglandin F2α ethyl amide
Bimatoprost是前列腺素类的类似物,用于控制青光眼和眼压增高的进展。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Bimatoprost, a synthetic prostamide F2α analog originally approved for the treatment of ocular hypertension and open-angle glaucoma, is now FDA approved as a 0.03%, solution to be applied once daily to increase eyelashes growth[3]. In March 2020, bimatoprost implant received its first approval, in the USA, for use to reduce intraocular pressure (IOP) in patient with open angle glaucoma or ocular hypertension[4]. |
| Concentration | Treated Time | Description | References | |
| human scleral fibroblast (SF) | 10 μM, 100 μM, 1000 μM | 24 h | To evaluate the effects of Bimatoprost on MMP gene expression. Bimatoprost dose-dependently upregulated MMP1 and MMP14 mRNA in all cell types. | Invest Ophthalmol Vis Sci. 2023 Mar 1;64(3):15. |
| human ciliary muscle (CM) | 10 μM, 100 μM, 1000 μM | 24 h | To evaluate the effects of Bimatoprost on MMP gene expression. Bimatoprost dose-dependently upregulated MMP1 and MMP14 mRNA in all cell types and MMP10 and MMP11 mRNA in TM and CM cells. | Invest Ophthalmol Vis Sci. 2023 Mar 1;64(3):15. |
| human trabecular meshwork (TM) | 10 μM, 100 μM, 1000 μM | 24 h | To evaluate the effects of Bimatoprost on MMP gene expression. Bimatoprost dose-dependently upregulated MMP1 and MMP14 mRNA in all cell types and MMP10 and MMP11 mRNA in TM and CM cells. In TM cells from normal eyes, mean MMP1 mRNA levels were 62.9-fold control levels at 1000 μM bimatoprost. | Invest Ophthalmol Vis Sci. 2023 Mar 1;64(3):15. |
| Human orbital fibroblasts (HOFs) | 100 nM | 12 days | To investigate the effects of PG analogs on the size of 3D organoids and ECM expression in HOFs. Results showed that PG analogs significantly inhibited adipogenesis-induced enlargement of organoids but had no effect on lipid metabolism. | Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):13. |
| Administration | Dosage | Frequency | Description | References | ||
| Beagle dogs | Normotensive model | Intracameral administration | 15 μg | Single administration, steady rate for 3 to 4 months | To evaluate the pharmacokinetics of Bimatoprost implant. In the iris-ciliary body tissue, the mean maximal drug concentration was 44 μM for intact bimatoprost and 494 nM for BFA. | Invest Ophthalmol Vis Sci. 2023 Mar 1;64(3):15. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.41mL 0.48mL 0.24mL |
12.03mL 2.41mL 1.20mL |
24.06mL 4.81mL 2.41mL |
|
| CAS号 | 155206-00-1 |
| 分子式 | C25H37NO4 |
| 分子量 | 415.57 |
| SMILES Code | O=C(NCC)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@@H]1O |
| MDL No. | MFCD03411999 |
| 别名 | AGN 192024; 17-phenyl trinor Prostaglandin F2α ethyl amide; Bimatoprostum; Latisse; Lumigan; 17-phenyl trinor PGF2α ethyl amide; 15(S)-Bimatoprost |
| 运输 | 蓝冰 |
| InChI Key | AQOKCDNYWBIDND-FTOWTWDKSA-N |
| Pubchem ID | 5311027 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 105 mg/mL(252.67 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1